The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance

Yuting Jiang, Guoliang Zhou, Qian Zhang and Shengtao Zhou

MedComm – Oncology, 2026, 5
DOI: 10.1002/mog2.70062

Phytocompounds Targeting Metabolic Reprogramming in Cancer: An Assessment of Role, Mechanisms, Pathways, and Therapeutic Relevance

Asifa Khan, Shumaila Siddiqui, Syed Akhtar Husain, Sybille Mazurek and Mohammad Askandar Iqbal

J. Agric. Food Chem., 2021, 69, 6897
DOI: 10.1021/acs.jafc.1c01173

3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment

Mingxue Li, Canrong Wu, Yueying Yang, Mengzhu Zheng, Silin Yu, Jinhui Wang, Lixia Chen and Hua Li

Cell Oncol., 2021, 44, 541
DOI: 10.1007/s13402-021-00599-9

A pharmacognostic approach for mitigating pancreatic cancer: emphasis on herbal extracts and phytoconstituents

Shruti Gupta, Atul Kumar and Kiran Kumar Tejavath

Futur J Pharm Sci, 2021, 7
DOI: 10.1186/s43094-021-00246-y

Cycling back to folate metabolism in cancer

Younghwan Lee, Karen H. Vousden and Marc Hennequart

Nat Cancer, 2024, 5, 701
DOI: 10.1038/s43018-024-00739-8

Dietary serine supplementation: Friend or foe?

Jingwen Jiang, Bowen Li, Weifeng He and Canhua Huang

Current Opinion in Pharmacology, 2021, 61, 12
DOI: 10.1016/j.coph.2021.08.011

Metabolic plasticity in the pancreatic cancer metastatic cascade

Biwen Zhu, Yibing Guo and Yuhua Lu

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026, 1881, 189622
DOI: 10.1016/j.bbcan.2026.189622

Target enzymes in serine‐glycine‐one‐carbon metabolic pathway for cancer therapy

Wei Sun, Erhu Zhao and Hongjuan Cui

Intl Journal of Cancer, 2023, 152, 2446
DOI: 10.1002/ijc.34353

Cytotoxic withanolides from the stems and leaves of Physalis ixocarpa

Ke Xiang, Yan Liu, Rui Zhu, Yang Xu, Dejuan Sun, Yueying Yang, Yushu Yan, Bingyou Yang, Hua Li and Lixia Chen

Food Chemistry, 2024, 439, 138136
DOI: 10.1016/j.foodchem.2023.138136

Chemical Components of the Fruits of Morus nigra Linn.: Methyl Caffeate as a Potential Anticancer Agent by Targeting 3-Phosphoglycerate Dehydrogenase

Yali Wang, Mengzhu Zheng, Qinghua Jiang, Yang Xu, Xuechen Zhou, Na Zhang, Dejuan Sun, Hua Li and Lixia Chen

J. Agric. Food Chem., 2021, 69, 12433
DOI: 10.1021/acs.jafc.1c03215

Structure‐Based Computational Approach in Search of the Potent Molecules Targeting Phosphoglycerate Dehydrogenase (PHGDH) Enzyme for Cancer Treatment

Priyanka Solanki, Anu Manhas, Dhaval Patel and Prakash Jha

ChemistrySelect, 2024, 9
DOI: 10.1002/slct.202403205

The connection between innervation and metabolic rearrangements in pancreatic cancer through serine

Mengmeng Dong, Lidong Cao, Ranji Cui and Yingjun Xie

Front. Oncol., 2022, 12
DOI: 10.3389/fonc.2022.992927

Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review 2015–2020

Quentin Spillier and Raphaël Frédérick

Expert Opinion on Therapeutic Patents, 2021, 31, 597
DOI: 10.1080/13543776.2021.1890028

Rhizosphere Bacteriobiome of the Husk Tomato Grown in the Open Field in West Siberia

Natalia B. Naumova, Oleg A. Savenkov, Tatiana Y. Alikina and Marsel R. Kabilov

Agriculture (Pol'nohospodárstvo), 2019, 65, 147
DOI: 10.2478/agri-2019-0015

Covalent binding of withanolides to cysteines of protein targets

Christian Bailly

Biochemical Pharmacology, 2024, 226, 116405
DOI: 10.1016/j.bcp.2024.116405

Structure–Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)

Quentin Spillier, Séverine Ravez, Judith Unterlass, Cyril Corbet, Charline Degavre, Olivier Feron and Raphaël Frédérick

Pharmaceuticals, 2020, 13, 20
DOI: 10.3390/ph13020020

Identification of novel PHGDH inhibitors based on computational investigation: an all-in-one combination strategy to develop potential anti-cancer candidates

Yujing Xu, Zhe Yang, Jinrong Yang, Chunchun Gan, Nan Qin and Xiaopeng Wei

Front. Pharmacol., 2024, 15
DOI: 10.3389/fphar.2024.1405350

Withanolides isolated from Tubocapsicum anomalum and their antiproliferative activity

Ke Xiang, Chen Li, Ming-Xue Li, Zhuo-Rui Song, Xiao-Xin Ma, De-Juan Sun, Hua Li and Li-Xia Chen

Bioorganic Chemistry, 2021, 110, 104809
DOI: 10.1016/j.bioorg.2021.104809

Metabolic characteristics in hepatocellular carcinoma: amino acid metabolic reprogramming

Ran Zhou, Yuejun Li, Guanghui Li, Yan Li, Lie Luo, Bin Wang and Liping Wang

Mol Cancer, 2026, 25
DOI: 10.1186/s12943-025-02492-7

Withanolides from dietary tomatillo suppress HT1080 cancer cell growth by targeting mutant IDH1

Yueying Yang, Ke Xiang, Dejuan Sun, Mengzhu Zheng, Zhuorui Song, Mingxue Li, Xuanbin Wang, Hua Li and Lixia Chen

Bioorganic & Medicinal Chemistry, 2021, 36, 116095
DOI: 10.1016/j.bmc.2021.116095

L-serine synthesis via the phosphorylated pathway in humans

Giulia Murtas, Giorgia Letizia Marcone, Silvia Sacchi and Loredano Pollegioni

Cell. Mol. Life Sci., 2020, 77, 5131
DOI: 10.1007/s00018-020-03574-z

A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight

Christine R. Cuthbertson, Zahra Arabzada, Armand Bankhead, Armita Kyani and Nouri Neamati

ACS Pharmacol. Transl. Sci., 2021, 4, 624
DOI: 10.1021/acsptsci.0c00223

Recent progress in serine metabolism reprogramming in tumors and strategies for serine deprivation

Huimei Liu and Yanping Liu

Front. Oncol., 2025, 15
DOI: 10.3389/fonc.2025.1669565

Inhibition of Serine Metabolism Promotes Resistance to Cisplatin in Gastric Cancer

Xiaoya Zhao, Jianfei Fu, Wanfen Tang, Liangliang Yu and Wenxia Xu

OTT, 2020, Volume 13, 4833
DOI: 10.2147/OTT.S246430

PHGDH at the crossroads: metabolic plasticity, metastatic paradoxes, and therapeutic reconnaissance in cancer

Liang Hao, Bai-Qiang Li, Shi-Yang Lu, Zhong-Cai An, Zheng-Yuan Yin, Zhen-Xian Du and Hua-Qin Wang

J Biomed Sci, 2026, 33
DOI: 10.1186/s12929-025-01205-y

Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors

Yuping Tan, Xia Zhou, Yanqiu Gong, Kun Gou, Youfu Luo, Da Jia, Lunzhi Dai, Yinglan Zhao and Qingxiang Sun

Cell. Mol. Life Sci., 2022, 79
DOI: 10.1007/s00018-021-04022-2

Separation and identification of tubocapsanolide MAP and tubocapsunolide A, and the structure-activity relationship of their anti-TNBC activity

PanTing Shou, Jiao Li, YingYing Wei, GuoYin Kai, FuQian Wang, HuaJun Zhao and Bo Yang

Steroids, 2020, 164, 108734
DOI: 10.1016/j.steroids.2020.108734

Unravelling the Allosteric Targeting of PHGDH at the ACT-Binding Domain with a Photoactivatable Diazirine Probe and Mass Spectrometry Experiments

Quentin Spillier, Séverine Ravez, Simon Dochain, Didier Vertommen, Léopold Thabault, Olivier Feron and Raphaël Frédérick

Molecules, 2021, 26, 477
DOI: 10.3390/molecules26020477

The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment

Xijia Zhou, Chang Tian, Yingshu Cao, Min Zhao and Ke Wang

Front. Genet., 2023, 13
DOI: 10.3389/fgene.2022.1084609

A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism

Jia-Ying Zhao, Kai-Rui Feng, Feng Wang, Jian-Wei Zhang, Jay Fei Cheng, Guo-Qiang Lin, Dingding Gao and Ping Tian

European Journal of Medicinal Chemistry, 2021, 217, 113379
DOI: 10.1016/j.ejmech.2021.113379

Physalis Genus, a Plant Source against Breast Cancer on MCF-7 Cell Line: A Systematic Review

Sakthi Priyadarsini Sethuraman, Sowmiya Velemurugan, Kamaraj Raju, Naveen Kumar Velayutham, Munawar Suhail Ahmed, Bharathi Santhanabharathi and M. Saiyad Musthafa

Curr. Pharmacol. Rep., 2024, 10, 454
DOI: 10.1007/s40495-024-00375-x

PHGDH as a therapeutic node: Natural modulators from TCM, degradation pathways, and emerging TPD strategies

Song-Song Shi, Yu-Dan Du, Si-Yi Chen, Wen Zhang, Guo-Wu Rao and Quan Zheng

Pharmacological Research, 2026, 224, 108079
DOI: 10.1016/j.phrs.2025.108079

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

Yuqiang Liu, Yu Zhao, Huisheng Song, Yunting Li, Zihao Liu, Zhiming Ye, Jianzhu Zhao, Yuzheng Wu, Jun Tang and Maojin Yao

Cancer Letters, 2024, 597, 217076
DOI: 10.1016/j.canlet.2024.217076

Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor BI-4924 Disrupts Serine Biosynthesis

Harald Weinstabl, Matthias Treu, Joerg Rinnenthal, Stephan K. Zahn, Peter Ettmayer, Gerd Bader, Georg Dahmann, Dirk Kessler, Klaus Rumpel, Nikolai Mischerikow, Fabio Savarese, Thomas Gerstberger, Moriz Mayer, Andreas Zoephel, Renate Schnitzer, Wolfgang Sommergruber, Paola Martinelli, Heribert Arnhof, Biljana Peric-Simov, Karin S. Hofbauer, Géraldine Garavel, Yvonne Scherbantin, Sophie Mitzner, Thomas N. Fett, Guido Scholz, Jens Bruchhaus, Michelle Burkard, Roland Kousek, Tuncay Ciftci, Bernadette Sharps, Andreas Schrenk, Christoph Harrer, Daniela Haering, Bernhard Wolkerstorfer, Xuechun Zhang, Xiaobing Lv, Alicia Du, Dongyang Li, Yali Li, Jens Quant, Mark Pearson and Darryl B. McConnell

J. Med. Chem., 2019, 62, 7976
DOI: 10.1021/acs.jmedchem.9b00718

Identification of benzo[b]thiophene-1,1-dioxide derivatives as novel PHGDH covalent inhibitors

Xin-Yu Cao, Xinge Li, Feng Wang, Yichen Duan, Xingmei Wu, Guo-Qiang Lin, Meiyu Geng, Min Huang, Ping Tian, Shuai Tang and Dingding Gao

Bioorganic Chemistry, 2024, 146, 107330
DOI: 10.1016/j.bioorg.2024.107330

Hidden in Plants—A Review of the Anticancer Potential of the Solanaceae Family in In Vitro and In Vivo Studies

Tomasz Kowalczyk, Anna Merecz-Sadowska, Patricia Rijo, Mattia Mori, Sophia Hatziantoniou, Karol Górski, Janusz Szemraj, Janusz Piekarski, Tomasz Śliwiński, Michał Bijak and Przemysław Sitarek

Cancers, 2022, 14, 1455
DOI: 10.3390/cancers14061455

Targeting aberrant amino acid metabolism for pancreatic cancer therapy: Opportunities for nanoparticles

Xinlong Zang, Ke Lei, Jia Wang, Ruining Gong, Chao Gao, Zhenghui Jing, Jinxiao Song and He Ren

Chemical Engineering Journal, 2024, 498, 155071
DOI: 10.1016/j.cej.2024.155071

Identification of Novel Natural Inhibitors to Human 3-Phosphoglycerate Dehydrogenase (PHGDH) for Cancer Treatment

Ayesha Sadiqa, Azhar Rasul, Mudassir Hassan, Salma Sultana and Farhat Jabeen

Molecules, 2022, 27, 6108
DOI: 10.3390/molecules27186108

Withanolides: Promising candidates for cancer therapy

Qiang Zhang, YongKang Yuan, Shijie Cao, Ning Kang and Feng Qiu

Phytotherapy Research, 2024, 38, 1104
DOI: 10.1002/ptr.8090

Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential

Md Mustahidul Islam, Shivani Kasana, Sakshi Priya, Balak Das Kurmi, Ghanshyam Das Gupta and Preeti Patel

Archiv der Pharmazie, 2025, 358
DOI: 10.1002/ardp.70083

Growth and immune effects of standardized Ashwagandha extract in whiteleg shrimp, Litopenaeus vannamei, post-larvae

Haitham G. Abo-Al-Ela, Mohammed Siddique, Zaki Z. Sharawy and Al-Azab Tahoun

Aquaculture, 2026, 617, 743758
DOI: 10.1016/j.aquaculture.2026.743758

Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy

Qi-qi Wang, Ming-xue Li, Chen Li, Xiao-xia Gu, Meng-zhu Zheng, Li-xia Chen and Hua Li

CURR MED SCI, 2020, 40, 205
DOI: 10.1007/s11596-020-2165-5

PHGDH: a metabolic switch in tumor drug resistance and a therapeutic target

Song-Song Shi, Si-Yi Chen, Wen Zhang, Guo-Wu Rao and Quan Zheng

Drug Discovery Today, 2026, 31, 104640
DOI: 10.1016/j.drudis.2026.104640

Phyto-Immunotherapy, a Complementary Therapeutic Option to Decrease Metastasis and Attack Breast Cancer Stem Cells

Susana Fiorentino, Claudia Urueña, Paola Lasso, Karol Prieto and Alfonso Barreto

Front. Oncol., 2020, 10
DOI: 10.3389/fonc.2020.01334

Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers

Wei Sun, Ruochen Liu, Xinyue Gao, Zini Lin, Hongao Tang, Hongjuan Cui and Erhu Zhao

Biomark Res, 2023, 11
DOI: 10.1186/s40364-023-00487-4